Guerbet SA
GBT
Company Profile
Business description
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
Contact
15 rue des Vanesses
Zone Paris Nord II
Villepinte93420
FRAT: +33 145915000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2024
Employees
1,057
Stocks News & Analysis
stocks
2 cheap miners after our commodity price update
These two companies are trading at a meaningful discount to our fair value.
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
stocks
Chart of the week: Where do our analysts see value?
This week's chart of the week looks at the under and overvalued sectors in the Australian market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,494.00 | 56.30 | -0.66% |
| CAC 40 | 7,350.90 | 58.67 | -0.79% |
| DAX 40 | 20,332.38 | 73.54 | -0.36% |
| Dow JONES (US) | 43,828.06 | 86.06 | -0.20% |
| FTSE 100 | 8,270.99 | 29.34 | -0.35% |
| HKSE | 19,795.49 | 175.75 | -0.88% |
| NASDAQ | 19,926.72 | 23.88 | 0.12% |
| Nikkei 225 | 39,457.49 | 12.95 | -0.03% |
| NZX 50 Index | 12,797.33 | 43.07 | 0.34% |
| S&P 500 | 6,051.09 | 0.16 | -0.00% |
| S&P/ASX 200 | 8,249.50 | 46.50 | -0.56% |
| SSE Composite Index | 3,386.33 | 5.55 | -0.16% |